Resistance Training Effects Vary Per Genetic Profiles

This article originally appeared here.
Share this content:
Resistance Training Effects Vary Per Genetic Profiles
Resistance Training Effects Vary Per Genetic Profiles

FRIDAY, May 22, 2015 (HealthDay News) -- Resistance training seems to be most effective for people with a low genetic risk for a high body mass index, according to a study published online April 30 in the International Journal of Obesity.

Researchers examined genetic markers of 148 women. They were between 30 and 65 years old. All participated in the year-long Bone Estrogen and Strength Training study. Each woman received a genetic risk score for obesity, which was based on 21 genetic markers believed to affect body weight.

Eighty-four women were asked to participate in supervised, high-intensity resistance training and moderate weight-bearing exercises. The exercise sessions lasted for 75 minutes each. The women were asked to do these exercises three days a week for one year. During this time, the women took calcium supplements but made no other changes to their typical diet. The participants recorded their food intake at random intervals.

The researchers found that the benefits of resistance training, which included weight loss as well as loss of body fat and abdominal fat, depended on a woman's genetics and her risk for obesity. More research is needed, the study authors pointed out. They said that future studies should include a more diverse group of people. And they added that future studies should also identify ideal weight-management strategies based on an individual's genetic profile.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Plan to Relax Coal-Fired Power Plant Rules Could Up Mortality

Plan to Relax Coal-Fired Power Plant Rules Could ...

EPA predicts between 470 and 1,400 premature deaths a year by 2030

FDA Extends EpiPen Expiration Dates to Tackle Shortage

FDA Extends EpiPen Expiration Dates to Tackle Shortage

Shortages due to factors such as supply disruptions and manufacturer issues

USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every three years from age 21; different screening options from age 30 to 65

is free, fast, and customized just for you!




Already a member?

Sign In Now »